We are not aware of pharmacological approaches that: (a) cause DR5 accumulation and oligomerization, and (b) stimulate downstream caspase activation and cancer cell death through mechanisms involving altered DR5 disulfide bonding. Here, TNFRSF10B is linked to cancer.